The price has closed above the downtrend line started this year with consistent volumes. I opened a buy as I am expecting increasing volume and strenght in the next sessions. Tps are already highlighted on the right.
CKPT is breaking out on heavy volume. Primary Wave 1 Extension Daily: Levels: Target:
A possible corrective structure may be completed on NASDAQ:ACAD . This could have big upside potential. If we get a consolidation here I'd love to start trading it on the radar.
keeping it simple! We have seemed to reach the bottom 2$ mark once again, and have indicators of a bounce to the top of the wedge, and possible breakout! I see the moku cloud turning bullish slightly, and buy signals in this area firing. We had a weekly sqeeze fire short, which seems to be slowing down right about now, with noticable increased volume over the...
Looking for a resistance level that causes a reversal of trend. You can see the 2.01 resistance level was hit on 9/6, and 9/7 the price fell through to 1.78. If the downward trend continues, the next resistance level to be hit would be 1.5. Substantial sell volume on 9/5, 9/6 and 9/7 could be indicative of a higher likelihood for a trend reversal early next...
Pharmaceutical company these are starting to become my new drug. Propah gains to be made! This thing moves fast af! bullish all the way.
As showed in the chart $BHC comes from a long bullish flag. Price is reaching the buy zone where the major bullish trendline goes through. It's not yet a buy but we are approching such zone. Strategy: watch and wait.
PGNX POTENTIAL LONG I had made a post on August 28th for a potential long opportunity on this pair. After letting the market play out for a few days it has given me a better structural trade and better looking potential long opportunity for what I like to trade. This pair had made a strong push from the $7.30 price area to the $9.30 price area back in late...
BLRX BL-8040 Overview BL-8040 is a novel, short peptide that functions as a high-affinity antagonist for CXCR4, which BioLineRx is developing for the treatment of solid tumors, acute myeloid leukemia, or AML, and stem-cell mobilization for bone-marrow transplantation. Solid Tumors: In January 2016, BioLineRx entered into a collaboration with MSD, known as ...
I read an article today that they are to provide the oils for CGC
PGNX POTENTIAL LONG 1W Chart: * on the weekly chart if you look at recent data it is displaying the fact that the recent buyers are a lot stronger than the sellers *one candle up from the buyer took out 6 candles down from the sellers 1D Chart: *on this chart it is displaying the fact that the recent buyer had pushed price up above 4H structure and seems to...
$Teva is still positive in the uptrend although the candle of yesterday has turned some indicators in bearish position. Over the mid term bullish trend is still strong. Having said that next candles have to be monitored because on a monthly basis there is a potential dragon fly bearish, thus a prompt recover toward the upper edge of the bullish flag is important...
I am waiting for an entry long in $BHC but positive signs are already there especially RSI is giving an insight, MA 200 is almost close and it might be probable a new test. Monthly RSI is down and on a weekly basis price is approcing the pullback of the third bullish wave. For the time being, given the positive earnings release a bullish trend continuation is...
ENDP Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines through excellence in development, manufacturing and commercialization. Through our operating companies – Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs – Endo is dedicated to serving patients in need. Endo commenced...
$MYL: Bullish wedge is about to be completed as yesterday we have seen rising bullish pressure, actually price wasn't able to break out the upper edge and we have seen a sharp intraday pullback (about 3%). Today buyers are coming in, thus price is heading upper edge. Volumes are rising, MACD on a weekly basis turn positive. Test of mid and long term support as...
Pharmaceutical stocks represents a defensive asset when a positive market cycle is about to finish or when it is foreseen a cycle less positive than the previous one. In such context pharma stocks should have an advantage because of inelastic demand for such goods. Novartis ($NVS,$NOVN) is one of the candidate to break up as the price is moving in a triangle...
Vertex has consolidating the price in a bullish wedge. A key resistence zone is at 178.57, a break out of such edge is interesting because it might pull up the price toward new high records. Stock is under the radar
Celgene helped by the company's buyback has turned positive after a complicated year. Despite this in terms of foundamentals two drugs are on the way to be developped but such developments will be revealed in the next year so patient is a must for those who wants to invest of something concreate. On a technical point of view yesterday price faild to cross MA 200....